Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikram Aggarwal

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
JMIR Research Protocols|September 21, 2022
Patient-Reported Outcome Dashboards Within the Electronic Health Record to Support Shared Decision-making: Protocol for Co-design and Clinical Evaluation With Patients With Advanced Cancer and Chronic Kidney DiseaseLaura M Perry, Victoria Morken, John D Peipert, et al.
BMJ Open Quality|January 12, 2025
Implementation of patient-reported outcome dashboards within the electronic health record to support shared decision-making in serious chronic illnessLaura M Perry, Nisha A Mohindra, Ava Coughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2024
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous CancersKara M Schenk, Julie Stein Deutsch, Sunandana Chandra, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 30, 2021
Renal Considerations in COVID-19: Biology, Pathology, and PathophysiologyMeghan E Kapp, Agnes B Fogo, Candice Roufouse, et al.
Journal for Immunotherapy of Cancer|September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKIShruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Kidney International|August 14, 2022
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancerShruti Gupta, Ian A Strohbehn, Qiyu Wang, et al.
Journal for Immunotherapy of Cancer|October 9, 2021
Acute kidney injury in patients treated with immune checkpoint inhibitorsShruti Gupta, Samuel A P Short, Meghan E Sise, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
JMIR Research Protocols|September 21, 2022
Patient-Reported Outcome Dashboards Within the Electronic Health Record to Support Shared Decision-making: Protocol for Co-design and Clinical Evaluation With Patients With Advanced Cancer and Chronic Kidney DiseaseLaura M Perry, Victoria Morken, John D Peipert, et al.
BMJ Open Quality|January 12, 2025
Implementation of patient-reported outcome dashboards within the electronic health record to support shared decision-making in serious chronic illnessLaura M Perry, Nisha A Mohindra, Ava Coughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2024
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous CancersKara M Schenk, Julie Stein Deutsch, Sunandana Chandra, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 30, 2021
Renal Considerations in COVID-19: Biology, Pathology, and PathophysiologyMeghan E Kapp, Agnes B Fogo, Candice Roufouse, et al.
Journal for Immunotherapy of Cancer|September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKIShruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Kidney International|August 14, 2022
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancerShruti Gupta, Ian A Strohbehn, Qiyu Wang, et al.
Journal for Immunotherapy of Cancer|October 9, 2021
Acute kidney injury in patients treated with immune checkpoint inhibitorsShruti Gupta, Samuel A P Short, Meghan E Sise, et al.
Pageof 5